147
Views
6
CrossRef citations to date
0
Altmetric
Original Research

The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland

, , , , , & show all
Pages 385-400 | Received 26 Aug 2016, Accepted 16 Nov 2016, Published online: 05 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tanja Novakovic, Antony P. Martin, Mark Parker, Alessandra Ferrario, Simo Vukovic, Krzysztof Łanda, Jaroslav Duba, Dávid Dankó, Nikolaos Kotsopoulos, Brian Godman, Jelena Ristic, Danka Stefanovic & Danka Tesic. (2017) The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia. Expert Review of Pharmacoeconomics & Outcomes Research 17:6, pages 519-521.
Read now

Articles from other publishers (5)

Hansoo Kim, Joshua Byrnes & Stephen Goodall. (2021) Health Technology Assessment in Australia: The Pharmaceutical Benefits Advisory Committee and Medical Services Advisory Committee. Value in Health Regional Issues 24, pages 6-11.
Crossref
Cristina Rais, Zoltán Kaló, Marcell Csanádi & Vlad Negulescu. (2020) Current and future perspectives for the implementation of health technology assessment in Romania. Health Policy and Technology 9:1, pages 45-52.
Crossref
Marcell Csanádi, Piotr Ozierański, Olga Löblová, Lawrence King, Zoltán Kaló & Lajos Botz. (2019) Shedding light on the HTA consultancy market: Insights from Poland. Health Policy 123:12, pages 1237-1243.
Crossref
Marcell Csanádi, Olga Löblová, Piotr Ozierański, András Harsányi, Zoltán Kaló, Martin McKee & Lawrence King. (2018) When health technology assessment is confidential and experts have no power: the case of Hungary. Health Economics, Policy and Law 14:2, pages 162-181.
Crossref
Piotr Ozierański, Olga Löblová, Natalia Nicholls, Marcell Csanádi, Zoltán Kaló, Martin McKee & Lawrence King. (2018) Transparency in practice: Evidence from ‘verification analyses’ issued by the Polish Agency for Health Technology Assessment in 2012–2015. Health Economics, Policy and Law 14:2, pages 182-204.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.